Close Menu

Swiss Institute of Bioinformatics

The new partnership will support the analysis of glycans in 30,000 human samples by the end of 2021.

Genome sequences of individuals from populations around the world provided insights into out-of-Africa migrations and Aboriginal Australian ancestry.

The Swiss Personalized Health Network will create a new national infrastructure for sharing clinical data among university hospitals, institutes, and others involved in health research.

Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.

The resource, which builds upon the contents of the SIB-developed UniProtKB/Swiss-Prot database, aims to be a comprehensive source for human protein data, integrating proteomics and protein research repositories. Commercial partner GeneBio also plans to offer a set of for-fee tools targeted at the pharma industry.

The Swiss group at Lausanne will work with collaborators to create a database and characterize human proteins.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.